I agree it likely will not have an immediate impac

I agree it likely will not have an immediate impact on the share price and there is a decent chance we don't even finish in the green again today (based on historical data).

However, I view these additional indications as positive for a few reasons:
1) Increases valuation if BP wants to go for BO......any phase 2 would most certainly hold weight with a BP valuation model even if the current share price does not reflect it.
2) They are relatively low cost pre-clinical trials and FDA filing fees to get to phase 2 to add value per statement 1.
3) I also don't think BOD is as concerned about financing as we are......they seems to know that raising additional funds is possible or that money is on the table from one or more BPs already.
4) At some point the share price will reflect some of this value if positive results continue. I think most are frustrated with the current share price, but very few that actually have done DD doubt in leronlimab being the real deal (even most of the CYDY and management doubters maintain positions simply based on the science). I'm ready for the BLA to be filed, financing resolved, mono pivotal trial to begin, interim cancer results, combo approval and any combination of the above to break us free......these are coming, just how much longer and will move the share price first?

Best of luck to you and all the longs!

Please do your own due diligence. All my posts and comments are not to be considered investment advice.